Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) announced that the Journal of Controlled Release has published the results of the first proof ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE